Evidence. Engagement. Excellence.
Turning evidence into engagement—and engagement into results.
Our Latest Thought Leadership
When the FDA’s Product Approval Standard Changes, So Must the Sales Standard
The FDA announced recently a shift toward allowing product approval based on one pivotal trial plus supporting evidence. In last week’s NEJM, FDA Commissioner Dr. Marty Makary and a top deputy, Dr. Vinay Prasad, state “in 2026 there are powerful alternative ways to feel assured that our products help people live longer or better than requiring manufacturers to test them yet again.”
From a sales perspective this is more than a regulatory adjustment. It’s a credibility moment for commercial teams.
As the FDA increases focus on “all aspects of study design with particular focus on controls, end points, effect size, and statistical protocols” so will HCPs.
When replication becomes less common in the approval package, HCPs naturally ask:
- How robust is this evidence?
- What are the limitations?
- How confident should I be in applying this to my patients?
This is exactly why the understanding of the principles of evidence-based medicine is even more mission-critical today.
Engaging HCPs with evidence isn’t about memorizing study results.
It’s about understanding:
- What the study actually proves
- What uncertainty remains
- How applicable the population is to real-world practice
- Whether endpoints are clinically meaningful
In a two-trial world, redundancy provided reassurance.
In a one-trial world, clarity replaces redundancy.
Sales teams who can confidently discuss:
- Minimal Clinically Important Difference (MCID)
- Confidence intervals
- Endpoint hierarchy
- External validity
- Supporting evidence limitations
will earn trust. Those who simply repeat “statistically significant” will not.
This isn’t about becoming medical science experts. It’s about raising the commercial standard to match the regulatory shift.
The FDA just adjusted the evidentiary bar.
High-performing sales organizations should do the same.
That’s Evidence-Based Engagement in action.
